CIBC Boosts WELL Health Technologies (TSE:WELL) Price Target to C$7.00

WELL Health Technologies (TSE:WELL) had its price target increased by research analysts at CIBC from C$5.25 to C$7.00 in a note issued to investors on Friday,BayStreet.CA reports. CIBC’s target price points to a potential upside of 3.70% from the company’s current price.

WELL has been the topic of a number of other research reports. Ventum Financial decreased their price objective on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th. Haywood Securities raised their price objective on WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday.

WELL Health Technologies Stock Performance

Shares of WELL Health Technologies stock traded down C$0.13 during trading hours on Friday, hitting C$6.75. 1,455,532 shares of the company were exchanged, compared to its average volume of 882,600. The business has a 50-day moving average of C$5.09 and a 200-day moving average of C$4.66. WELL Health Technologies has a 1 year low of C$3.41 and a 1 year high of C$7.02. The stock has a market capitalization of C$1.68 billion, a price-to-earnings ratio of 11.84, a P/E/G ratio of -1.93 and a beta of 1.20. The company has a current ratio of 1.25, a quick ratio of 1.02 and a debt-to-equity ratio of 41.57.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.